Go to the list of all blogs
Serhii Bondarenko's Avatar
published in Blogs
Sep 25, 2026
SPDR Gold Shares (GLD) Climbs +6.5% This Quarter Despite a Recent Pullback

SPDR Gold Shares (GLD) Climbs +6.5% This Quarter Despite a Recent Pullback

Key Takeaways

  • SPDR Gold Shares (GLD) is a physically backed exchange-traded fund (ETF) that tracks the spot price of gold bullion rather than an index of equities.
  • Over the past quarter, GLD has advanced roughly 6.5%, while the most recent 30 days brought a pullback of about 6.6% from its late-summer highs.
  • The recent cooling reflects shifting interest-rate expectations, a firmer U.S. dollar, and profit-taking after a rapid rally.
  • Real yields, the dollar, inflation trends, and central-bank gold demand remain the primary variables shaping the fund's trajectory.

SPDR Gold Shares (GLD) Overview

GLD, launched in November 2004, is one of the largest and most liquid physically backed gold ETFs in the world. Unlike equity funds, GLD is structured as a grantor trust that holds allocated London Good Delivery gold bars in secured vaults. Its objective is to reflect the performance of the price of gold bullion, less the trust's expenses.

Because the fund is backed by physical metal, its portfolio has no traditional sector allocation or list of equity holdings. Exposure is effectively 100% gold bullion, with the net asset value (NAV) tracking the London Bullion Market Association (LBMA) Gold Price. The fund carries an expense ratio of 0.40% and operates as a passive, physically backed vehicle, meaning its returns are driven almost entirely by movements in the gold price itself. I also checked this using Tickeron’s AI Screener to see how the fund compares to other commodity vehicles.

Industry and Thematic Landscape

Gold behaves as a monetary and safe-haven asset rather than an industrial commodity, and its price is set by a handful of macro forces. The most important is the level of real interest rates: when inflation-adjusted bond yields fall, the opportunity cost of holding non-yielding gold declines, which tends to support prices. Conversely, rising real yields can pressure gold.

The U.S. dollar is a second key driver. Gold is priced in dollars globally, so a stronger greenback generally weighs on the metal, while dollar weakness is typically supportive. Inflation expectations, Federal Reserve policy, and geopolitical risk also matter, with gold often drawing safe-haven demand during periods of uncertainty. On the demand side, central banks have been sustained net buyers of gold for several years, adding a structural layer of support beneath the market.

Performance and Positioning Snapshot

GLD's recent behavior illustrates the metal's sensitivity to these macro drivers. Over the past quarter, the fund has climbed roughly 6.5%, extending a broader uptrend in gold. However, the most recent 30 days have been more volatile: after a sharp advance that carried GLD to fresh multi-year highs near $428, the fund pulled back by approximately 6.6% as of the latest available session, settling in the low-to-mid $390s.

This pattern—a strong rally followed by consolidation—points to a combination of factors. The late-summer surge reflected investor appetite for gold amid shifting monetary-policy expectations and safe-haven positioning. The subsequent pullback coincided with a rebound in the U.S. dollar, a backup in Treasury yields, and profit-taking after an unusually fast ascent. ETF inflows and outflows have also amplified these swings, as physically backed funds like GLD must adjust their bullion holdings in response to investor demand. From what I see, monitoring these flows alongside price action is important.

2026 Outlook and Key Factors to Monitor

Looking ahead, GLD's trajectory will depend heavily on the path of monetary policy. If the Federal Reserve signals a slower pace of easing or real yields continue to climb, gold could face headwinds. Conversely, a more accommodative stance or renewed expectations of rate cuts would tend to support the metal.

Inflation data and the direction of the U.S. dollar will also be central, as a sustained period of dollar strength has historically weighed on gold. Central-bank buying remains a structural tailwind worth monitoring, along with ETF flows, which can amplify both rallies and pullbacks in physically backed funds. Geopolitical developments and episodes of market stress could periodically revive safe-haven demand, while the pace of global economic growth may influence whether investors favor gold over risk assets. None of these factors guarantee a particular price outcome, but together they define the environment most likely to shape GLD's performance in the months ahead. I’m watching this closely as rate decisions unfold.

Using Tickeron’s AI Screener for Research

I also checked this using Tickeron’s AI Screener to see how the fund compares to others in the industry. Tickeron’s AI Screener is an AI-powered stock and ETF discovery platform that helps investors scan thousands of securities using technical indicators, fundamentals, volatility measures, AI-generated signals, market trends, price patterns, and customizable filters. The tool is designed to surface trending securities, breakout candidates, and new trading opportunities more efficiently than manual screening, allowing users to compare ETFs and equities across industries, sectors, and performance characteristics. For investors monitoring gold, commodities, or broader market rotation, the AI Screener provides a structured way to identify candidates and refine a watchlist with a neutral, data-driven approach.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: GLD

Contributor

Serhii Bondarenko is an AI-focused trading strategist and financial markets analyst specializing in the development and application of AI trading bots and autonomous trading agents. His work combines technical analysis, fundamental analysis, and quantitative research to identify market patterns, forecast price movements, and analyze liquidity, volatility, and correlations across global stock markets. Serhii actively publishes market insights, forecasts, and trading frameworks on platforms such as Investing.com and Finextra, with a strong focus on AI-driven decision-making and next-generation algorithmic trading. His research aims to bridge the gap between traditional trading methodologies and advanced artificial intelligence, helping traders and investors navigate complex and rapidly evolving market conditions.


GLD's RSI Indicator leaves overbought zone

The 10-day RSI Indicator for GLD moved out of overbought territory on August 26, 2026. This could be a sign that the stock is shifting from an upward trend to a downward trend. Traders may want to look at selling the stock or buying put options. Tickeron's A.I.dvisor looked at 45 instances where the indicator moved out of the overbought zone. In 38 of the 45 cases the stock moved lower in the days that followed. This puts the odds of a move down at 84%.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on September 23, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on GLD as a result. In 55 of 88 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 62%.

The Moving Average Convergence Divergence Histogram (MACD) for GLD turned negative on August 31, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 51 similar instances when the indicator turned negative. In 36 of the 51 cases the stock turned lower in the days that followed. This puts the odds of success at 71%.

GLD moved below its 50-day moving average on September 23, 2026 date and that indicates a change from an upward trend to a downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where GLD declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 65%.

GLD broke above its upper Bollinger Band on August 24, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for GLD entered a downward trend on September 24, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 46 of 54 cases where GLD's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 85%.

Following a +2.41% 3-day Advance, the price is estimated to grow further. Considering data from situations where GLD advanced for three days, in 295 of 346 cases, the price rose further within the following month. The odds of a continued upward trend are 85%.

Industry description

The investment seeks to reflect the performance of the price of gold bullion, less the expenses of the Trust’s operations. The Trust holds gold bars and from time to time, issues Baskets in exchange for deposits of gold and distributes gold in connection with redemptions of Baskets. The investment objective of the Trust is for the Shares to reflect the performance of the price of gold bullion, less the Trust’s expenses. The Sponsor believes that, for many investors, the Shares represent a cost-effective investment in gold.
View a ticker or compare two or three
GLD
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

Category CommoditiesBroadBasket

Category
Commodities Focused
Address
444 Madison Ave, 3rd Flc/o World Gold Trust Services, LLCNew York
Phone
N/A
Web
http://www.spdrs.com
Interact to see
Advertisement
INSM shares are surging approximately +10% in premarket trading on Monday, March 23, 2026, from a prior close of $136.00, placing the premarket price near $149.60. The primary catalyst is the release of positive topline results from the Phase 3 ENCORE trial of ARIKAYCE® in patients with newly diagnosed or recurrent MAC (Mycobacterium avium complex) lung disease — a readout Insmed had flagged as expected in "March or April 2026".
CF shares are trading approximately -6% lower in Monday's premarket session, dropping from a Friday close of $124.90 to approximately $117.41. Primary catalyst: President Trump announced a five-day pause on strikes against Iranian energy infrastructure following "very good" diplomatic signals, triggering a sharp unwind of the geopolitical risk premium embedded in fertilizer stocks.
APGE shares surged approximately 16% in premarket trading on March 23, 2026, after the company announced positive 52-week data from Part A of its Phase 2 APEX clinical trial. The primary catalyst is a highly anticipated clinical readout showing that zumilokibart (APG777) delivered durable and deepening responses in patients with moderate-to-severe atopic dermatitis at both every 3-month and 6-month dosing intervals.
Shares of VALN are plummeting approximately 35% in Monday's session, from a Friday close of $10.66 to roughly $6.93, in heavy volume trading. The primary catalyst is the release of Phase 3 VALOR trial topline results for Valneva's Lyme disease vaccine candidate, co-developed with PFE (Pfizer) — results that showed strong clinical efficacy but failed to meet the pre-determined statistical criterion for the primary endpoint.
AXTI is surging approximately +11.00% in Monday's session, trading near $60.21, up from a prior closing price of $54.24. The move extends the stock's post-earnings rally that began last Thursday when shares jumped more than 19% following AXT's Q4 2025 results.
Tower Semiconductor (TSEM) shares are surging approximately +10% intraday on Monday, March 23, trading around $180, up from the previous close of $163.63 on March 20, 2026. The primary catalyst is the opening day of APEC 2026 in San Antonio, Texas, where Tower Semiconductor is presenting its newly unveiled Gen3 BCD power management platform designed to address escalating AI data center power demands.
CD is indicated down about 17% in premarket trading after the latest completed session, pointing to a sharp negative market reaction heading into the open. The stock’s weakness comes against a backdrop of lingering uncertainty following its privatization and delisting process from Nasdaq, which has left limited liquidity and a thinner news flow around the name.
SEDG is indicated down roughly 9% in premarket trading, following a strong advance in the prior regular session. The pullback comes after shares rallied on optimism around new product launches and an analyst upgrade, leaving the stock vulnerable to profit-taking and volatility.
NTGR shares surged approximately 11% in premarket trading on March 24, 2026, building on a roughly 20% overnight jump in the prior session. The primary catalyst is a landmark Federal Communications Commission (FCC) ruling that prohibits all imports of consumer routers manufactured overseas, citing national security concerns.
ANNA is surging approximately +20.00% in Tuesday's premarket session, rebounding sharply from Monday's -22.84% decline. The primary catalyst remains the ongoing U.S.-Iran military conflict, which disrupted Qatari LNG exports and drove European benchmark natural gas prices to multi-year highs.
Concentrix Corporation (CNXC) shares are falling approximately 11% in Tuesday's premarket session after the company released its fiscal Q1 2026 earnings report before market open. Adjusted diluted EPS came in at $2.61, missing the Wall Street consensus estimate of approximately $2.64.
Shares of Karyopharm Therapeutics (KPTI) are trading approximately 12% lower in Tuesday's premarket session, with the previous close at $7.63. The primary catalyst is the March 24 release of topline Phase 3 SENTRY trial data, in which the company met only one of two co-primary endpoints.
IBRX shares are down approximately 23% in Tuesday's session, trading near $7.24 after closing at $9.40 on Monday, March 23. The sharp decline follows an 11%+ surge in the prior session, with profit-taking and valuation pressure cited as primary triggers.
Shares of Circle Internet Group (CRCL) are down approximately 9% in Tuesday morning trading, extending a pullback from recent multi-month highs above $126. The primary catalyst appears to be a broad crypto-sector risk-off wave, with Bitcoin sliding below $69,000 and the Fear & Greed Index dropping to extreme fear territory.
ALM shares are indicated down about 11% in early Tuesday trading after closing the prior session at $16.93. The move comes after a powerful multi‑month rally that took the stock from below $3 to an intraday high of $22.55 earlier in March, leaving it vulnerable to profit-taking and volatility.​
LUNR shares are indicated down about 7% in Tuesday premarket trading after closing the last regular session at $20.31. The pullback follows a powerful rally driven by strong 2026 revenue guidance of $900 million–$1 billion and upbeat analyst commentary, including price target hikes and buy ratings.
MAZE shares are trading approximately 27% lower in premarket on March 25, 2026, after the company reported its highly anticipated Phase 2 HORIZON trial topline data for lead drug candidate MZE829. The catalyst is a dual announcement: Phase 2 clinical data for MZE829 in APOL1-mediated kidney disease (AMKD) alongside Q4 and full-year 2025 financial results.
ARM shares surged approximately +10% in premarket trading on March 25, 2026, hitting $148.6 from a prior close of approximately $135. The primary catalyst is Arm's historic strategic pivot: the company announced it will begin selling its own self-developed AGI CPU chips, breaking its decades-long "IP licensing only" business model.
Shares of Enliven Therapeutics (ELVN) are surging approximately +15% in premarket trading on March 25, 2026, driven by renewed investor enthusiasm around the company's advancing clinical program for ELVN-001 in chronic myeloid leukemia (CML). The stock's prior closing price on March 24, 2026 was $31.15, placing the premarket indicated price near $35.82.
AVXL shares are down approximately 29% in premarket trading on Wednesday, March 25, 2026, falling to roughly $2.97 from the prior close of $4.19. The primary catalyst is Anavex's formal withdrawal of its marketing authorization application (MAA) for blarcamesine from the European Union, announced in the early hours of March 25, 2026.